Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust

Eran Klein, A. J. Solomon, J. Corboy, J. Bernat

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background Perceived physician financial conflicts of interest of can affect patient trust. Payment to physicians for industry sponsored clinical trials in multiple sclerosis is a relatively new potential source of physician conflict of interest. There is limited available data on how physician payment for trial involvement in multiple sclerosis clinical trials may influence patient trust. Objective To understand how patient trust is influenced by information about physician payment for multiple sclerosis clinical trials. Methods An anonymous online instrument was developed. Results 597 people with multiple sclerosis participated in the study. The study found that 61% of patients who had not previously participated in a clinical trial estimated that they would have lower levels of trust in their physician if the physician was paid for involvement in their clinical trial. Among former clinical trial participants, 38% self-reported a lower level of trust. Other potential physician-industry relationships, such as industry consulting or giving industry-sponsored talks, also adversely affected trust, though to a lesser extent than physician payment for subject participation in clinical trials. Conclusions Results of this study demonstrate that physician payment for study participation in multiple sclerosis clinical trials is a potential conflict that can adversely affect patient trust.

Original languageEnglish (US)
Pages (from-to)4-8
Number of pages5
JournalMultiple Sclerosis and Related Disorders
Volume8
DOIs
StatePublished - Jul 1 2016

Fingerprint

Multiple Sclerosis
Industry
Clinical Trials
Physicians
Conflict of Interest

Keywords

  • Clinical trials
  • Conflict of interest
  • Industry-sponsored clinical trials
  • Multiple sclerosis
  • Professional conduct and ethics
  • Trust

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust. / Klein, Eran; Solomon, A. J.; Corboy, J.; Bernat, J.

In: Multiple Sclerosis and Related Disorders, Vol. 8, 01.07.2016, p. 4-8.

Research output: Contribution to journalArticle

@article{3cc1277839dd438fa86933eae3319191,
title = "Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust",
abstract = "Background Perceived physician financial conflicts of interest of can affect patient trust. Payment to physicians for industry sponsored clinical trials in multiple sclerosis is a relatively new potential source of physician conflict of interest. There is limited available data on how physician payment for trial involvement in multiple sclerosis clinical trials may influence patient trust. Objective To understand how patient trust is influenced by information about physician payment for multiple sclerosis clinical trials. Methods An anonymous online instrument was developed. Results 597 people with multiple sclerosis participated in the study. The study found that 61{\%} of patients who had not previously participated in a clinical trial estimated that they would have lower levels of trust in their physician if the physician was paid for involvement in their clinical trial. Among former clinical trial participants, 38{\%} self-reported a lower level of trust. Other potential physician-industry relationships, such as industry consulting or giving industry-sponsored talks, also adversely affected trust, though to a lesser extent than physician payment for subject participation in clinical trials. Conclusions Results of this study demonstrate that physician payment for study participation in multiple sclerosis clinical trials is a potential conflict that can adversely affect patient trust.",
keywords = "Clinical trials, Conflict of interest, Industry-sponsored clinical trials, Multiple sclerosis, Professional conduct and ethics, Trust",
author = "Eran Klein and Solomon, {A. J.} and J. Corboy and J. Bernat",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.msard.2016.04.001",
language = "English (US)",
volume = "8",
pages = "4--8",
journal = "Multiple Sclerosis and Related Disorders",
issn = "2211-0348",
publisher = "Elsevier",

}

TY - JOUR

T1 - Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust

AU - Klein, Eran

AU - Solomon, A. J.

AU - Corboy, J.

AU - Bernat, J.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Background Perceived physician financial conflicts of interest of can affect patient trust. Payment to physicians for industry sponsored clinical trials in multiple sclerosis is a relatively new potential source of physician conflict of interest. There is limited available data on how physician payment for trial involvement in multiple sclerosis clinical trials may influence patient trust. Objective To understand how patient trust is influenced by information about physician payment for multiple sclerosis clinical trials. Methods An anonymous online instrument was developed. Results 597 people with multiple sclerosis participated in the study. The study found that 61% of patients who had not previously participated in a clinical trial estimated that they would have lower levels of trust in their physician if the physician was paid for involvement in their clinical trial. Among former clinical trial participants, 38% self-reported a lower level of trust. Other potential physician-industry relationships, such as industry consulting or giving industry-sponsored talks, also adversely affected trust, though to a lesser extent than physician payment for subject participation in clinical trials. Conclusions Results of this study demonstrate that physician payment for study participation in multiple sclerosis clinical trials is a potential conflict that can adversely affect patient trust.

AB - Background Perceived physician financial conflicts of interest of can affect patient trust. Payment to physicians for industry sponsored clinical trials in multiple sclerosis is a relatively new potential source of physician conflict of interest. There is limited available data on how physician payment for trial involvement in multiple sclerosis clinical trials may influence patient trust. Objective To understand how patient trust is influenced by information about physician payment for multiple sclerosis clinical trials. Methods An anonymous online instrument was developed. Results 597 people with multiple sclerosis participated in the study. The study found that 61% of patients who had not previously participated in a clinical trial estimated that they would have lower levels of trust in their physician if the physician was paid for involvement in their clinical trial. Among former clinical trial participants, 38% self-reported a lower level of trust. Other potential physician-industry relationships, such as industry consulting or giving industry-sponsored talks, also adversely affected trust, though to a lesser extent than physician payment for subject participation in clinical trials. Conclusions Results of this study demonstrate that physician payment for study participation in multiple sclerosis clinical trials is a potential conflict that can adversely affect patient trust.

KW - Clinical trials

KW - Conflict of interest

KW - Industry-sponsored clinical trials

KW - Multiple sclerosis

KW - Professional conduct and ethics

KW - Trust

UR - http://www.scopus.com/inward/record.url?scp=84963981971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963981971&partnerID=8YFLogxK

U2 - 10.1016/j.msard.2016.04.001

DO - 10.1016/j.msard.2016.04.001

M3 - Article

C2 - 27456867

AN - SCOPUS:84963981971

VL - 8

SP - 4

EP - 8

JO - Multiple Sclerosis and Related Disorders

JF - Multiple Sclerosis and Related Disorders

SN - 2211-0348

ER -